LSA
RVMD icon

Leonteq Securities AG’s Revolution Medicines RVMD Stock Holding History

Leonteq Securities AG’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Buy
+637
New +$93K ﹤0.01% 663
2026
Q1 		– Sell
-300
Closed -$23.9K – 1461
2025
Q4 		$23.9K Buy
+300
New +$19.7K ﹤0.01% 1060
2025
Q1 		– Sell
-479
Closed -$21K – 1331
2024
Q4 		$21K Sell
479
-55
-10% -$2.78K ﹤0.01% 964
2024
Q3 		$24.2K Sell
534
-100
-16% -$4.35K ﹤0.01% 888
2024
Q2 		$24.6K Buy
634
+449
+243% +$16.8K ﹤0.01% 893
2024
Q1 		$5.96K Buy
+185
New +$5.48K ﹤0.01% 1062

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Leonteq Securities AG's RVMD Position: Q2 2026 in Review

Leonteq Securities AG opened a new position in Revolution Medicines (RVMD) in Q2 2026: 637 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #663 among its holdings. This is a return to the name: Leonteq Securities AG previously reported a position in RVMD as recently as Q4 2025.

Leonteq Securities AG first reported a position in RVMD in Q1 2024 and has held it in 6 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Leonteq Securities AG held 637 shares of Revolution Medicines worth $119K as of Q2 2026.
  • Revolution Medicines was a new Leonteq Securities AG position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #663 holding.
  • Leonteq Securities AG first reported a position in Revolution Medicines in Q1 2024 and has held it in 6 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.